Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0NV9O
|
|||
Former ID |
DIB000122
|
|||
Drug Name |
BAY 10-00394
|
|||
Synonyms |
roniciclib; BAY 1000394; BAY 10-00394; KB-145902; 1223498-69-8; Tube010; SCHEMBL875845; GTPL7874
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162.9] | Discontinued in Phase 2 | [1], [2] | |
Company |
Bayer healthcare pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H21F3N4O3S
|
|||
Canonical SMILES |
CC(C(C)OC1=NC(=NC=C1C(F)(F)F)NC2=CC=C(C=C2)S(=N)(=O)C3CC3)O
|
|||
InChI |
1S/C18H21F3N4O3S/c1-10(26)11(2)28-16-15(18(19,20)21)9-23-17(25-16)24-12-3-5-13(6-4-12)29(22,27)14-7-8-14/h3-6,9-11,14,22,26H,7-8H2,1-2H3,(H,23,24,25)/t10-,11-,29?/m1/s1
|
|||
InChIKey |
UELYDGOOJPRWGF-MFOHZAOFSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7874). | |||
REF 2 | BAY 1000394, a novel cyclin-dependent kinase inhibitor, with potent antitumor activity in mono- and in combination treatment upon oral application. Mol Cancer Ther. 2012 Oct;11(10):2265-73. | |||
REF 3 | National Cancer Institute Drug Dictionary (drug id 770319). | |||
REF 4 | Liposarcoma: molecular genetics and therapeutics. Sarcoma. 2011;2011:483154. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.